High Expression of CD109 Antigen Regulates the Phenotype of Cancer Stem-Like Cells/Cancer-Initiating Cells in the Novel Epithelioid Sarcoma Cell Line ESX and Is Related to Poor Prognosis of Soft Tissue Sarcoma

High SOX2 Levels Predict Better Outcome in Non-Small Cell Lung Carcinomas

(2013) Vamsidhar Velcheti et al.   PLoS One

CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts

(2012) Xiao-Yong Man et al.   ARTHRITIS RESEARCH & THERAPY

INI1-Deficient Tumors

(2011) Travis J. Hollmann et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

The TGF-β co-receptor, CD109, promotes internalization and degradation of TGF-β receptors

(2011) Albane A. Bizet et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

TGF-β signal transduction spreading to a wider field: a broad variety of mechanisms for context-dependent effects of TGF-β

(2011) Hiroaki Ikushima et al.   CELL AND TISSUE RESEARCH

SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity

(2011) Munehide Nakatsugawa et al.   LABORATORY INVESTIGATION

Detection of specific genetic abnormalities by fluorescence in situ hybridization in soft tissue tumors

(2011) Yasuhiro Miura et al.   PATHOLOGY INTERNATIONAL

High Aldehyde Dehydrogenase Activity Identifies Tumor-Initiating and Metastasis-Initiating Cells in Human Prostate Cancer

(2010) Christel van den Hoogen et al.   CANCER RESEARCH

Processing of CD109 by furin and its role in the regulation of TGF-β signaling

(2010) S Hagiwara et al.   ONCOGENE

Correlation of pathological grade and tumor stage of urothelial carcinomas with CD109 expression

(2010) Minako Hagikura et al.   PATHOLOGY INTERNATIONAL

High ALDH Activity Identifies Chemotherapy-Resistant Ewing's Sarcoma Stem Cells That Retain Sensitivity to EWS-FLI1 Inhibition

(2010) Ola Awad et al.   PLoS One

Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas

(2009) M Murase et al.   BRITISH JOURNAL OF CANCER

ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients’ outcome

(2009) Ting Li et al.   LABORATORY INVESTIGATION

Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer

(2009) F. Jiang et al.   MOLECULAR CANCER RESEARCH

Prognostic impact and immunogenicity of a novel osteosarcoma antigen, papillomavirus binding factor, in patients with osteosarcoma

(2008) Tomohide Tsukahara et al.   CANCER SCIENCE

Stem Cells, the Molecular Circuitry of Pluripotency and Nuclear Reprogramming

(2008) Rudolf Jaenisch et al.   CELL

Clonal T-cell response against autologous pleomorphic malignant fibrous histiocytoma antigen presented by retrieved HLA-A*0206

(2007) Shigeharu Kimura et al.   JOURNAL OF ORTHOPAEDIC RESEARCH